I have accumulated over the past 5 years to build a substantial holding over this period. With a major milestone now so close I certainly won’t be parting with a single share.
I can’t understand how the market cap of this company has remained at $50M as the phase 2 trial progresses in line with plan and the phase 1 patients continue to improve several years after implant. IIL for example who are currently in phase 2 trials with results expected at the same time as NTCELL has increase to a market cap of $300M.
Despite the lack of media attention when phase 2 results are released the results will speak for themselves where long term holders will be rewarded. 2017 is a make or break year for LCT, we'll either be at 2 cents or 50 cents by the end of the year….
- Forums
- ASX - By Stock
- Final, Group 3, Phase II Trials
I have accumulated over the past 5 years to build a substantial...
-
- There are more pages in this discussion • 136 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AI (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 6044404 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 1428165 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 6044404 | 0.006 |
11 | 4577719 | 0.005 |
6 | 3695009 | 0.004 |
2 | 3100000 | 0.003 |
2 | 1050000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 1428165 | 3 |
0.008 | 2252112 | 10 |
0.009 | 2028673 | 10 |
0.010 | 2788587 | 5 |
0.011 | 208125 | 2 |
Last trade - 16.12pm 14/10/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online